MavenView

MavenView

At MavenVue, we drive research to commercialization and benefits to end-users.

Founded 2015

Columbus, United States 3 employees Seed Total: $2.44M Analytics, Biopharma +3

MavenView, founded in 2015 and headquartered in the United States, is at the forefront of transforming research into impactful solutions. Upholding its slogan, "At MavenVue, we drive research to commercialization and benefits to end-users," the company operates within the Analytics, Biopharma, Biotechnology, Information Technology, and Life Sciences industries.

MavenView offers strategic insights for health and life science professionals, enabling thorough exploration of connections and patterns critical for innovation. Its offerings include high-level overviews and in-depth analysis of technologies, biological therapies, and rare diseases. This supports competitive intelligence, licensing, and M&A activities, catering to evolving industry needs.

The company last secured a $737.74K Seed Round investment on 02 October 2018. This funding illustrates investor confidence in MavenView’s potential to leverage strategic intelligence within the biopharma and life sciences space.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	$737.74K	-		02 Oct 2018
Seed Round	$100.00K	-		01 Jan 2018
Seed Round	$765.00K	-		06 Dec 2017
Seed Round	$835.00K	2	Rev1 Ventures, Ohio TechAngels Fund	24 Oct 2017
Seed Round	Undisclosed	1	Rev1 Ventures	10 Oct 2016

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

$737.74K

02 Oct 2018

Seed Round

$100.00K

01 Jan 2018

Seed Round

$765.00K

06 Dec 2017

Seed Round

$835.00K

Rev1 Ventures, Ohio TechAngels Fund

24 Oct 2017

Seed Round

Undisclosed

Rev1 Ventures

10 Oct 2016

FAQ About MavenView

At MavenVue, we drive research to commercialization and benefits to end-users.

MavenView was founded in 2015.

MavenView is headquartered in Columbus, United States.

MavenView operates in Analytics, Biopharma, Biotechnology, Information Technology and Life Sciences. Its work centres on Health & Life Sciences, Innovation Strategy, Competitive Intelligence and Commercialization Support. Its customers include Health and life science professionals, Competitive intelligence professionals and Research strategists.

MavenView has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Service Fee and Data Monetization.

MavenView has approximately 3 employees.

MavenView has completed 5 funding rounds, raising a total of $2.44M. The latest funding stage is Seed.

MavenView offers: Business and medical intelligence software, Competitive activity tracking, Emerging technology identification, Research and investment decision support, IP monetization and commercialization support, Non-obvious relationship discovery.

Top alternatives and competitors to MavenView include GlobalData Plc, Mekonos Inc., IP Checkups, Inc., Macro Trials, GreyB. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

MavenView and GlobalData Plc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About MavenView

Services & Products

Target Customers

Funding Rounds & Investors (5)

MavenView Alternatives & Competitors

FAQ About MavenView